RAD ASX Chart
Snapshot
Radiopharm Theranostics Limited (RAD) operates as a clinical stage radiotherapeutics organisation developing a platform of radiopharmaceutical products for diagnostic and therapeutic use in areas of unmet medical need. The development pipeline consists of platform technologies that include peptides, small molecules, and monoclonal antibodies for cancer applications.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | - |
| vs ASX 200 (1yr) | -10.92% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Carlton South VIC 3053 |
| Website | www.radiopharmtheranostics.com |
| Registry | MUFG Corporate Markets (AU) Limited |
| Auditor | Grant Thornton Audit Pty Ltd |
| Date Listed | 25 Nov 2021 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 28/08/2026 | Report (Prelim) |
| 16/09/2026 | Report (Annual) |
| 26/02/2027 | Report (Interim) |
Former Company Names
- Radiopharm Theranostics Ltd has no former company names.
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
RAD directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of RAD directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Lantheus Omega, LLC | 09/12/2025 | 537,958,513 | 15.18 |
| Regal Funds Management Pty Ltd | 24/10/2025 | 223,468,219 | 9.01 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 09-12-25 | Lantheus Omega, LLC | 255,000,000 | 12.12 | 15.18 |
| 24-10-25 | Regal Funds Management Pty Ltd | 78,015,022 | 6.30 | 9.01 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 09-12-25 | Paul Hopper | 147,721,428 | 5.30 | -- |
| 26-11-25 | JPmorgan Chase & Co. and its affiliates | 160,916,855 | 5.79 | -- |
| 24-10-25 | JPmorgan Chase & Co. and its affiliates | 13,666,559 | 7.48 | 5.79 |
| 24-10-25 | Paul Hopper | 1,500,000 | 6.90 | 5.30 |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $0.022 | 30 June |
| 2024 | $0.038 | 28 June |
| 2023 | $0.105 | 30 June |
| 2022 | $0.15 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.